Glucosamine Market, Global
MARKET OVERVIEW:
The global glucosamine market size was valued at USD 230 million in 2024. The market is projected to grow from USD 240 million in 2025 to USD 307 million by 2032, exhibiting a CAGR of 4.3% during the forecast period.
Glucosamine is an amino sugar and a key precursor in the biochemical synthesis of glycosylated proteins and lipids. It plays a structural role in polysaccharides such as chitosan and chitin, making it one of the most abundant monosaccharides. Commercially, glucosamine is primarily produced through the hydrolysis of shellfish exoskeletons, though
MARKET INSIGHT & GROWTH DRIVERS:
USD 230 million USD 240 million 4.3% Click Here for More Detailed
The market growth is driven by increasing demand from the health food and pharmaceutical sectors, particularly for joint health supplements
MARKET SEGMENTATION:
MARKET DYNAMICS
Rising Prevalence of Osteoarthritis to Fuel
Glucosamine Demand
The global glucosamine market is witnessing significant growth driven by the increasing prevalence of osteoarthritis, a degenerative joint disease affecting over 500 million people worldwide. As the most common joint disorder, osteoarthritis creates substantial demand for joint health supplements, with glucosamine sulfate emerging as one of the most clinically studied nutritional interventions for managing symptoms. Recent studies indicate glucosamine may help reduce joint pain by nearly 30% compared to placebo while slowing cartilage degradation, making it a preferred choice for aging populations seeking natural
MARKET OPPORTUNITIES
Advancements in microbial fermentation present significant opportunities for market expansion. Plant-based and fermentation-derived glucosamine, currently representing about 15% of production, addresses allergen concerns associated with shellfish while offering manufacturers greater supply chain control. Several companies are investing in optimized microbial strains that can produce high-purity glucosamine at competitive costs, with recent technological breakthroughs reducing fermentation cycle times by 30%.
COMPANY MISSION
Boron neutron capture therapy (BNCT) is emerging as a promising cancer treatment modality, particularly for difficult-to-treat tumors like glioblastoma. Japan has led clinical adoption with over 200 patients treated since 2020, while China and Europe are ramping up clinical trials. The precision targeting capability of boron-10, when irradiated with low-energy neutrons, minimizes damage to healthy tissues - a significant advantage over conventional radiotherapy. Pharmaceutical companies are investing in boron-containing drug development, with several boron-10 based compounds currently in Phase II/III trials for various oncology indications.
REGIONAL MARKET OUTLOOK
North America
The North American glucosamine market remains one of the largest consumers globally, driven by high awareness of joint health supplements and a growing aging population. The U.S. accounts for nearly 72% of regional demand, fueled by widespread acceptance of dietary supplements and preventive healthcare trends. However, regulatory scrutiny from the FDA regarding health claims has led manufacturers to focus on clinical researchbacked formulations. The presence of leading players like Cargill and TSI further strengthens the competitive landscape. While growth is steady, market saturation in core supplement categories presents challenges for new entrants.
Europe
Europe represents a mature yet innovation-driven glucosamine market, with Germany and the U.K. leading consumption. Stringent EU regulations on nutraceutical labeling and shellfish-derived ingredient safety have pushed manufacturers toward vegetable-sourced or fermentation-based production methods. The region shows increasing preference for combination products (glucosamine-chondroitin-MSME) in pharmaceutical applications. Sustainability concerns are reshaping supply chains, with buyers prioritizing Marine Stewardship Council-certified raw materials. Despite pricing pressures
COMPETITIVE LANDSCAPE
• KOYO Chemical (Japan)
• Cargill (U.S.)
• YSK (China)
• Bayir Chemicals (Turkey)
• Panvo Organics (India)
• TSI Group (U.S.)
• Wellable Marine Biotech (China)
• Golden-Shell Pharmaceutical (China)
These companies represent some of the major key players driving innovation and growth in the market, contributing significantly to global supply and competitive dynamics.
• Aoxing Biotechnology (China)
DOWNLOAD FREE SAMPLE PDF
About Us
Founded in 2015, 24chemicalresearch is a trusted name in global chemical industry intelligence. We specialize in delivering high-quality market research reports, empowering over 30+ Fortune 500 clients with data-driven insights for strategic growth. Our team of experienced analysts delivers customized, reliable, and timely research backed by a rigorous methodology. From mining regulatory trends to forecasting market opportunities, our reports help companies navigate industry challenges, stay competitive, and grow confidently.
As a one-stop platform for the chemical sector, we offer:
• Deep specialization in chemical market analysis
• Customized reports tailored to your needs
• A robust portal with free samples, consulting, and competitive insights
